GLOBUS MEDICAL, INC. Expense Breakdown
No Expense Breakdown for GMED on this site yet.
- 2026-06-30: Reportable $210.50M.
- 2025-06-30: Reportable $213.16M.
Source checked: the stored Expense Breakdown page for GMED.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $210.50M |
| 2025-06-30 | $213.16M |
Cost Of Goods And Services Sold Depreciation: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $30.93M |
| 2025-06-30 | $29.64M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |